These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14595861)

  • 1. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses.
    Zhang H; Zhang D; Ray K
    J Mass Spectrom; 2003 Oct; 38(10):1110-2. PubMed ID: 14595861
    [No Abstract]   [Full Text] [Related]  

  • 2. An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data.
    Zhu P; Tong W; Alton K; Chowdhury S
    Anal Chem; 2009 Jul; 81(14):5910-7. PubMed ID: 19518135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of bile acid methyl esters by gas chromatography methane chemical ionization mass spectrometry.
    Muschik GM; Wright LH; Schroer JA
    Biomed Mass Spectrom; 1979 Jun; 6(6):266-70. PubMed ID: 476290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retention-time-shift-tolerant background subtraction and noise reduction algorithm (BgS-NoRA) for extraction of drug metabolites in liquid chromatography/mass spectrometry data from biological matrices.
    Zhu P; Ding W; Tong W; Ghosal A; Alton K; Chowdhury S
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1563-72. PubMed ID: 19408276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies.
    Tiller PR; Yu S; Bateman KP; Castro-Perez J; McIntosh IS; Kuo Y; Baillie TA
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3510-6. PubMed ID: 18853407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography-electrospray ionisation mass spectrometry.
    Smyth WF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):1-20. PubMed ID: 16095984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for characterization of drug metabolites using liquid chromatography-tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approaches.
    Liu DQ; Hop CE
    J Pharm Biomed Anal; 2005 Feb; 37(1):1-18. PubMed ID: 15664738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive mass spectrometric detection of neutral bile acid metabolites. Formation of adduct ions with an organic anion in atmospheric pressure chemical ionization.
    Goto T; Shibata A; Iida T; Mano N; Goto J
    Rapid Commun Mass Spectrom; 2004; 18(19):2360-4. PubMed ID: 15384160
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass fragmentography in drug research.
    Carrington R; Frigerio A
    Drug Metab Rev; 1977; 6(2):243-82. PubMed ID: 344022
    [No Abstract]   [Full Text] [Related]  

  • 10. Broad range analysis of endocrine disruptors and pharmaceuticals using gas chromatography and liquid chromatography tandem mass spectrometry.
    Trenholm RA; Vanderford BJ; Holady JC; Rexing DJ; Snyder SA
    Chemosphere; 2006 Dec; 65(11):1990-8. PubMed ID: 16949633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A strategy for metabolite identification using triple-quadrupole mass spectrometry with enhanced resolution and accurate mass capability.
    Jemal M; Ouyang Z; Zhao W; Zhu M; Wu WW
    Rapid Commun Mass Spectrom; 2003; 17(24):2732-40. PubMed ID: 14673820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to the assessment of stable and chemically reactive drug metabolites in early clinical trials.
    Baillie TA
    Chem Res Toxicol; 2009 Feb; 22(2):263-6. PubMed ID: 19216579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the analytical behaviour of selected new molecular entities using electrospray ionisation ion trap mass spectrometry, liquid chromatography, gas chromatography and polarography and their determination in serum at therapeutic concentrations.
    Rodríguez Robledo V; Smyth WF
    Anal Chim Acta; 2008 Aug; 623(2):221-30. PubMed ID: 18620927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.
    Espina R; Yu L; Wang J; Tong Z; Vashishtha S; Talaat R; Scatina J; Mutlib A
    Chem Res Toxicol; 2009 Feb; 22(2):299-310. PubMed ID: 18980340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry.
    Pozo OJ; Van Thuyne W; Deventer K; Van Eenoo P; Delbeke FT
    J Mass Spectrom; 2008 Mar; 43(3):394-408. PubMed ID: 18035854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.
    Ma S; Subramanian R
    J Mass Spectrom; 2006 Sep; 41(9):1121-39. PubMed ID: 16967439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative mass spectrometry in biochemistry and medicine.
    Lehmann WD; Schulten HR
    Angew Chem Int Ed Engl; 1978 Apr; 17(4):221-38. PubMed ID: 418711
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine.
    Tsutsumi H; Katagi M; Miki A; Shima N; Kamata T; Nishikawa M; Nakajima K; Tsuchihashi H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):315-22. PubMed ID: 15833296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.